Several studies have demonstrated that key signaling pathways such as phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) are activated in both benign and higher grade meningiomas [10,11,12,13]. The gene discussed is WNK2; the disease is meningioma.